Did You Invest in the Royal Bank of Scotland’s Callable Capped CMS Steepener Notes Due December 2030 (CUSIP: 78009KPR7)?
According to RBS’s prospectus on CUSIP: 78009KPR7:
Investors are advised that any prices shown on any website or Bloomberg page are indicative prices only and, as such, there can be no assurance that any trade could be executed at such prices.
Investors ought to be cautious with this type of investment. According to the Financial Industry Regulatory Authority (FINRA):
If you bought the structured product known as RBS Callable Capped CMS Steepener Notes Due December 2030 CUSIP: 78009KPR7, and it was sold to you as a safe, liquid, and/or conservative investment, and then you suffered losses, you may have a claim. Contact the attorneys at Sonn Law Group for free consultation.
Image credit: Elliott Brown via Flickr